Month: December 2020

SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire as President and CEO effective January 12, 2021. Mr. King will continue to serve on iRhythm’s board of directors and as an advisor to the business. Effective the same date, Mike Coyle will join the company as President and CEO and as a member of its board of directors.Under King’s leadership, iRhythm successfully completed an IPO in 2016, achieved record financial growth and increased shareholder value significantly. During his tenure, the company’s annual revenue grew from approximately $5 million in 2011 to projected analyst consensus of $263 million in 2020, while increasing its market capitalization...

Dubuque, IA, Dec. 14, 2020 (GLOBE NEWSWIRE) — DUBUQUE, IA – Heartland Financial USA, Inc. (“Heartland”), a diversified financial services company with 11 community banks in the Midwest, Southwest and Western United States, announced that Christopher S. Hylen will serve as an independent director on the Heartland Board of Directors.“With more than 25 years of technology and business leadership experience, Chris is a high-caliber executive who brings a special depth of knowledge and perspective to the Heartland Board of Directors,” commented Lynn B. Fuller, Executive Operating Chairman. “We will benefit from his executive-level leadership, his vast experience in using technology to enable extraordinary client experiences and his laser focus on delivering value to clients and shareholders,” added Fuller.Christopher Hylen is an experienced...

Rochester Hills, Michigan, Dec. 14, 2020 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that Rich DiIorio, Chief Executive Officer and Barry Steele, Chief Financial Officer, will present at the 13th Annual LD Micro Main Event at 3:00 p.m. ET on Tuesday, December 15, 2020, on a virtual platform.To register for the virtual event, visit: https://ve.mysequire.comView InfuSystem’s company profile here: http://www.ldmicro.com/profile/INFUAbout InfuSystem Holdings, Inc.InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment...

WESTFORD, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced it received two orders to supply recycled fiber processing systems from a containerboard producer in Asia with a value of approximately $10 million. The equipment will be used to process recycled corrugated boxes and produce top liner used in corrugated packaging. The orders were booked in the fourth quarter of 2020 and are expected to ship in 2021.“We are pleased to have been selected to supply the fiber processing systems for these recycled containerboard machines,” said Jeffrey L. Powell, president and chief executive officer of Kadant. “Our leading position in fiber processing technology combined with our strong reputation for providing high-performance equipment were critical factors in being awarded this order.”About KadantKadant Inc. is a...

SANTA MONICA, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) — Leaf Group Ltd. (NYSE: LEAF), a diversified consumer internet company, today announced the closing of its underwritten public offering of 8,216,750 shares of its common stock, including full exercise of the underwriter’s option to purchase additional shares of common stock, at a public offering price of $4.20 per share. All shares of common stock sold in the offering were sold by Leaf Group.Leaf Group received aggregate net proceeds from the offering of approximately $32.0 million, after deducting the underwriting discounts and commissions and estimated offering expenses payable by Leaf Group. Leaf Group intends to use the net proceeds from the offering for working capital and general corporate purposes. Leaf Group may also use a portion of the net proceeds to acquire complementary...

BEIJING, Dec. 14, 2020 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier-neutral and cloud-neutral data center services provider in China, today announced that on December 14, 2020, Mr. Tao Zou, a director of the Company nominated by King Venture Holdings Limited (“King Venture”) in accordance with an Investor Rights Agreement dated as of January 15, 2015 by and among the Company, King Venture and certain other parties (the “Investor Rights Agreement”), informed the Company’s board of directors of his decision to resign from the board with immediate effect due to personal reasons. The resignation of Mr. Zou did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company would like...

A total of 510 patients enrolledEvents required to trigger interim superiority analysis accruedInterim superiority analysis expected in Q1 2021; final analysis in Q4 2021LYON, France and CAMBRIDGE, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the completion of enrollment in the TRYbeCA-1 Phase 3 trial in second-line pancreatic cancer.TRYbeCA-1, the pivotal Phase 3 clinical trial evaluating ERYTECH’s lead product candidate, eryaspase, in second-line metastatic pancreatic cancer, has completed patient enrollment. A total of 510 patients participated in the trial, slightly above the target enrollment of 482 patients.The trial recently...

Un total de 510 patients recrutésAtteinte du nombre d’événements requis pour déclencher l’analyse intermédiaire d’efficacitéAnalyse intermédiaire d’efficacité et analyse finale respectivement attendues au 1ertrimestre 2021 et au 4èmetrimestre 2021LYON, France, 14 déc. 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les globules rouges, annonce aujourd’hui la finalisation du recrutement dans l’étude de phase 3 TRYbeCA-1 dans le traitement en seconde ligne du cancer du pancréas.TRYbeCA-1, l’essai clinique pivot de phase 3 évaluant le produit candidat phare d’ERYTECH, eryaspase, dans le traitement de seconde ligne du cancer du pancréas métastatique, a terminé...

PARIS, 14 déc. 2020 (GLOBE NEWSWIRE) — Cellectis S.A. (Nasdaq: CLLS – Euronext Growth: ALCLS), société biopharmaceutique de stade clinique spécialisée dans le développement d’immunothérapies fondées sur les cellules CAR-T allogéniques ingénierées (UCART), annonce le lancement, sous réserve des conditions de marché, d’une offre au public aux Etats-Unis et d’une offre adressée uniquement à des investisseurs qualifiés dans certains autres pays, portant sur un montant total de 100 millions de dollars d’American Depositary Shares (ADS), chacune représentant une action ordinaire Cellectis. Dans le contexte de cette offre, Cellectis envisage de consentir aux banques garantes une option de sur-allocation leur permettant de souscrire, pendant 30 jours, un nombre d’ADS additionnels représentant au maximum 15% du nombre d’ADS initialement...